As of today (2024-05-27), Certara's share price is €14.995.
Certara's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €0.35. Hence, Certara's Price-to-Free-Cash-Flow Ratio for today is 42.36.
The historical rank and industry rank for Certara's Price-to-Free-Cash-Flow or its related term are showing as below:
HAM:700'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 24.2 Med: 47.7 Max: 160.62
Current: 43.68
During the past 6 years, Certara's highest Price-to-Free-Cash-Flow Ratio was 160.62. The lowest was 24.20. And the median was 47.70.
HAM:700's Price-to-Free-Cash-Flow is ranked worse than 80.62% of 356
companies
in the Healthcare Providers & Services industry
Industry Median: 16.765
vs HAM:700: 43.68
During the past 12 months, the average Free Cash Flow per Share Growth Rate of Certara was -24.20% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 15.20% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 160.00% per year.
During the past 6 years, Certara's highest 3-Year average Free Cash Flow per Share Growth Rate was 600.70% per year. The lowest was 15.20% per year. And the median was 39.20% per year.
Certara Price-to-Free-Cash-Flow Historical Data
The historical data trend for Certara's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Certara's Price-to-Free-Cash-Flow
For the Health Information Services subindustry, Certara's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Certara's Price-to-Free-Cash-Flow Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Certara's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Certara's Price-to-Free-Cash-Flow falls into.
Certara Price-to-Free-Cash-Flow Calculation
Certara's Price-to-Free-Cash-Flow ratio for today is calculated as
Certara's Share Price of today is €14.995. Certara's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.35.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Certara Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Certara's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The group has a business presence in the United States, EMEA, and other regions, of which a majority of revenue is derived from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HAM:700 has been successfully added to your 